Amarin Pharma, Inc., Amarin Pharmaceuticals Ireland Limited, Mochida Pharmaceutical… v. Hikma Pharmaceuticals USA Inc., Hikma Pharmaceuticals Plc

N OTE: This order is nonprecedential.
United States Court of Appeals
for the Federal Circuit
______________________
AMARIN PHARMA, INC., AMARIN
PHARMACEUTICALS IRELAND LIMITED,
MOCHIDA PHARMACEUTICAL CO., LTD.,
Plaintiffs-Appellants
v.
HIKMA PHARMACEUTICALS USA INC., HIKMA
PHARMACEUTICALS PLC,
Defendants-Appellees
HEALTH NET LLC,
Defendant
______________________
2023-1169
______________________
Appeal from the United States District Court for the
District of Delaware in No. 1:20-cv-01630-RGA-JLH, Judge
Richard G. Andrews.
______________________
SUA SPONTE
______________________
Before M OORE, Chief Judge, MAYER and L OURIE, Circuit
Judges
______________________
Case: 23-1169 Document: 82 Page: 1 Filed: 07/15/2026

-- 1 of 2 --

AMARIN PHARMA, INC. v. HIKMA PHARMACEUTICALS USA INC. 2
P ER CURIAM .
O R D E R
Upon consideration of the judgment of the Supreme
Court of the United States in Hikma Pharmaceuticals USA
Inc., et al. v. Amarin Pharma, Inc., et al., No. 24-889,
I T I S O RDERED T HAT :
The mandate of this court that issued October 24, 2024,
is recalled, the appeal is reinstated, and this court’s June
25, 2024, opinion and judgment are vacated. We further
remand this case to the United States District Court for the
District of Delaware for further proceedings consistent
with the Supreme Court’s decision.
July 15, 2026
Date
F OR THE COURT
Case: 23-1169 Document: 82 Page: 2 Filed: 07/15/2026

-- 2 of 2 --